We have previously demonstrated that a human glioblastoma cell line, T98G cells, produced high levels of interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) when stimulated with IL-1 or tumor necrosis factor-α (TNF-α). In this study, we found that T98G cells are capable of producing large amounts of IL-8 and MCP-1 when cocultured with human peripheral blood monocytes or a monocytic cell line, U937 cells. Since it is possible that both glioblastoma cells and monocytes are capable of producing chemokines, we determined which type of cells actually produced IL-8 and MCP-1, by the fixation of one or the other cell type with 3% paraformaldehyde (PA). This procedure revealed that T98G cells were the main source and that PA-treated monocytes effectively stimulated IL-8 and MCP-1 production by T98G cells. Both IL-8 and MCP-1 gene expression and protein production by T98G cells were confirmed by northern blot as well as immunohistochemical staining methods. To analyze the molecules on human monocytes responsible for inducing IL-8 and MCP-1 by T98G cells, several antibodies (Abs) as well as IL-1 receptor antagonist (IL-1Ra) were tested. Anti-IL-1α Ab and IL-1Ra almost completely abolished the IL-8/MCP-1-inducing capacity of the PA-fixed monocytes, while no inhibition was obtained with anti-IL-1β, anti-TNF-α or Abs against CD11b/18, L-selectin or ICAM-1, indicating that membrane-associated IL-1α is involved in the IL-8/MCP-1 induction, while secreted IL-1α plays a major role in this cell-to-cell, i.e., juxtacrine interaction in unfixed conditions.
|Number of pages||9|
|Journal||European Cytokine Network|
|Publication status||Published - 1998 Jun 2|
- IL-1 receptor antagonist
ASJC Scopus subject areas
- Immunology and Allergy
- Clinical Biochemistry